Patient Characteristics
| Characteristic | All patients (n = 104) |
| Median age (y) | 67.4 (range, 38–84) |
| Clinical tumor stage | |
| T1a | — |
| T1b | — |
| T1c | 39 |
| T2a | 1 |
| T2b | 1 |
| T2c | 25 |
| T3a | 7 |
| T3b | 26 |
| T4 | 5 |
| N0 | 72 |
| N1 | 32 |
| M0 | 82 |
| M1a | 3 |
| M1b | 17 |
| M1c | 2 |
| GS (biopsy) | |
| 6 | 15 |
| 7a | 24 |
| 7b | 16 |
| 8 | 19 |
| 9 | 26 |
| 10 | 4 |
| Current PSA | |
| <10 ng/mL | 35 |
| 10–20 ng/mL | 30 |
| >20 ng/mL | 38 |
| Unknown | 1 |
| d’Amico score (21) | |
| Low risk | 6 |
| Intermediate risk | 17 |
| High risk | 81 |